Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes

NCT04961489 | Completed DMC

• 1 other identifier: 2020/2706
• Study Type: observational
• Target: 11,000
• Locations: 1 country
• Sites: 2

Brief Summary

This study aims to look at the impact on patient outcomes arising from measures implemented during the COVID-19 pandemic. The information and knowledge from this study will be useful for the management and allocation of hospital resources and patients in tne event of a disease outbreak.

Conditions

Surgery

Keywords

Covid-19 pandemic; emergency; cancer; elective surgery; postponement

Outcome Measures

Primary Outcomes (2)

• Analysis of patients according to type of surgical procedures, medical condition and dates of surgical treatment retrospectively.

  These patients are classified according to the institution, type of surgical procedures, the medical condition and the dates of surgical treatment. The study will be compared across four time periods.

  1 Jan - 31 Dec 2017, 1 Jan - 31 Dec 2018, 1 Jan - 31 Dec 2019, 1 Jan - 31 Dec 2020

• Comparing surgical indices for high volume cancer and non-cancer diagnoses

  The study focus on surgical indices for selected high-volume cancer and non-cancer diagnoses over the period 1st January2020 to 31 December 2020 and compare them with similar indices across the same period of time in the preceding 3 years in particular, for the following surgical procedures: 1. Surgeries for the following cancer diagnoses: 1. breast cancer, \[XIV- N60, no malignancy\], \[Malignant, IINeoplasms- C50\], colorectal cancer, \[C18, 19, 20\], 2. hepatocellular carcinoma, \[C22\] 2. Selected non-cancer surgeries: 1. Cholecystectomy 2. Abdominal hernia repair

  1 Jan 2020 - 31 Dec 2020

Eligibility Criteria

• Age: 21 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

This study seeks to assess the effect of the measures taken to contain COVID 19 on patients who need surgical services measured by patient outcomes, such as, length of hospital stay (LOS), ICU stay, APACHE score, and stage of cancer at surgery.

You may qualify if:

• This study involves the extraction of patient records from the enterprise dataware house. As such, we do not stipulate the age limits.
• Patients who had the following surgeries during over the period of 1 Jan 2017 to 31 December 2020
• From the identified surgical procedure type or the following cancer-related procedures:
• Breast
• Colon
• Liver
• Rectum
• Selected non-cancer surgeries:
• Abdominal Wall
• Gallbladder
• Patients from SGH and its related institute NCC
• Only local Singapore Citizens

Sponsors & Collaborators

• National Cancer Centre, Singapore: lead
• National Medical Research Council (NMRC), Singapore: collaborator

Study Sites (2)

Singapore General Hospital

Singapore, 169608, Singapore

Location

National Cancer Center Singapore

Singapore, 169690, Singapore

Location

Related Publications (2)

• Mazingi D, Navarro S, Bobel MC, Dube A, Mbanje C, Lavy C. Exploring the Impact of COVID-19 on Progress Towards Achieving Global Surgery Goals. World J Surg. 2020 Aug;44(8):2451-2457. doi: 10.1007/s00268-020-05627-7.

  PMID: 32488665 BACKGROUND

• Al-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, O'Neill N, Iosifidis C, Griffin M, Mathew G, Agha R. Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation). Int J Surg. 2020 Jul;79:233-248. doi: 10.1016/j.ijsu.2020.05.002. Epub 2020 May 12.

  PMID: 32413502 BACKGROUND

Related Links

• A Comparison of Statistical Modeling Strategies for Analyzing Length of Stay after CABG Surgery. Health Services and Outcomes Research Methodology

MeSH Terms

Conditions

COVID-19; Emergencies; Neoplasms

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Pierce Chow, MD, PhD

  National Cancer Centre, Singapore

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 12, 2021
• First Posted: July 14, 2021
• Study Start: August 1, 2020
• Primary Completion: March 31, 2021
• Study Completion: March 31, 2021
• Last Updated: July 14, 2021

Record last verified: 2021-07

Data Sharing

• IPD Sharing: Will not share

Locations

SG (2)